Cyclin D: Subunit of The Cyclin D Complex and Regulator of Cell Cycle

Target Name: Cyclin D

NCBI ID: P22874

Cyclin D

Other Name(s): None

Cyclin D: Subunit of The Cyclin D Complex and Regulator of Cell Cycle

Cyclin D, also known as cyclin D1, is a protein that is found in all living cells. It plays a critical role in the cell cycle, which is the process by which a cell grows, replicates its DNA, and divides. Cyclin D is a key component of the G1 phase of the cell cycle, which is when the cell prepares for cell division.

Cyclin D is a subunit of the cyclin D complex, which consists of several proteins that work together to regulate the cell cycle. The cyclin D subunit is composed of two large alpha helix structure, alpha helix is 鈥嬧?媋 secondary structure composed of multiple Composed of repeating helical units. These helical units are encoded by a core 伪-helix gene, which encodes a protein containing a central 尾 and a surrounding 伪-helix.

One of the key features of Cyclin D is its ability to interact with other proteins. This interaction is crucial for the regulation of the cell cycle and the growth and development of the cell. Cyclin D has been shown to interact with several proteins, including the transcription factor, p21, which plays a critical role in the regulation of cell growth and apoptosis.

Another protein that interacts with Cyclin D is the protein p53, which is a well-known tumor suppressor protein. p53 has been shown to interact with Cyclin D and regulate the cell cycle in response to various stressors, such as UV radiation and certain chemicals.

In addition to its interaction with p21 and p53, Cyclin D has also been shown to interact with several other proteins. These include the protein Ku70, which is involved in the regulation of DNA replication, and the protein p16, which is involved in the regulation of cell apoptosis.

Cyclin D is also known as cyclin D1 because it is one of the four subunits of the cyclin D subcomplex that is involved in regulating the cell cycle. The other three subunits are cyclin D2, cyclin D3, and cyclin D4. These subunits are involved in different aspects of the cell cycle and have different functions.

One of the functions of Cyclin D is to regulate the level of the protein p21 in the cell. p21 is a transcription factor that plays a critical role in the regulation of cell growth and apoptosis. High levels of p21 have been shown to promote the growth and survival of cancer cells, while low levels of p21 have been shown to inhibit the growth and survival of cancer cells.

In addition to regulating the level of p21, Cyclin D is also involved in the regulation of the other proteins that interact with it, including p53 and Ku70. These proteins have been shown to work together with Cyclin D to regulate the cell cycle and the growth and development of the cell.

Cyclin D is also an attractive drug target for several reasons. First, it is a protein that is expressed in all living cells, which makes it an attractive target for drugs that can be administered to all parts of the body. Second, Cyclin D is involved in several key processes in the cell cycle, which makes it an attractive target for drugs that can regulate the cell cycle.

Third, Cyclin D has been shown to play a critical role in the regulation of cell apoptosis, which is the process by which a cell undergoes death. This makes it an attractive target for drugs that can promote cell survival and prevent cell death.

Finally, Cyclin D is a good candidate for a drug because it has been shown to interact with several other proteins, including the transcription factor, p21, which plays a critical role in the regulation of cell growth and apoptosis. This interaction makes it

Protein Name: Cyclin D (nonspecified Subtype)

The "Cyclin D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Cyclin D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets